Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (231-240 of 550) with videos related to

Pageof 55
Sort By:
Experimental Hematology|January 1, 1973
Active immunotherapy in spontaneous leukemia of AkR miceG Mathé, O Halle-Pannenko, C Bourut
Cancer Research|November 1, 1985
Decrease of metastatogenic potential by pregraft treatment of Lewis lung carcinoma cells with proteinase and protein kinase affinity labelsK W Stahl, G Mathé, G Kovacs
European Journal of Cancer|October 1, 1977
Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumourG Mathé, O Halle-Pannenko, C Bourut
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Restoration of aging reduced immunity is possible with immunomodulators and is applicable to cancer treatment and preventionG Mathé, I Florentin, M Bruley-Rosset
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 30, 1976
Effect of pre- and post-surgical active BCG immunotherapies on murien EAkR lymphosarcomaF Economides, M Bruley-Rosset, G Mathé
National Cancer Institute Monograph|December 1, 1973
BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapyG Mathé, O Halle-Pannenko, C Bourut
The British Journal of Surgery|April 1, 1971
An experimental tumour model for the study of the effects of chemotherapy and immunotherapy in combination with surgeryH S Winsey, G Mathé, R Thompson
Lancet (London, England)|March 12, 1977
Clinical significance and prognostic value of the T-B immunological classification of human primary acute lymphoid leukaemiasA J Davies, D Belpomme, G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1983
[Phase II comparative trials for confirmation of the null hypothesis. Their interest, particularly in oncology]J L Misset, H Gaget, G Mathé
Transplantation Proceedings|June 1, 1976
Use of soluble histocompatibility antigen(s) in the control of transplantation reactions: possible dissociation of the roles of H-2 and non-H-2 antigens in the prevention of mortality induced by graft-versus-host reactionO Halle-Pannenko, N Abuaf, G Mathé
Pageof 55

Showing results (231-240 of 550) with videos related to

Sort By:
Pageof 55
Experimental Hematology|January 1, 1973
Active immunotherapy in spontaneous leukemia of AkR miceG Mathé, O Halle-Pannenko, C Bourut
Cancer Research|November 1, 1985
Decrease of metastatogenic potential by pregraft treatment of Lewis lung carcinoma cells with proteinase and protein kinase affinity labelsK W Stahl, G Mathé, G Kovacs
European Journal of Cancer|October 1, 1977
Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumourG Mathé, O Halle-Pannenko, C Bourut
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Restoration of aging reduced immunity is possible with immunomodulators and is applicable to cancer treatment and preventionG Mathé, I Florentin, M Bruley-Rosset
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 30, 1976
Effect of pre- and post-surgical active BCG immunotherapies on murien EAkR lymphosarcomaF Economides, M Bruley-Rosset, G Mathé
National Cancer Institute Monograph|December 1, 1973
BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapyG Mathé, O Halle-Pannenko, C Bourut
The British Journal of Surgery|April 1, 1971
An experimental tumour model for the study of the effects of chemotherapy and immunotherapy in combination with surgeryH S Winsey, G Mathé, R Thompson
Lancet (London, England)|March 12, 1977
Clinical significance and prognostic value of the T-B immunological classification of human primary acute lymphoid leukaemiasA J Davies, D Belpomme, G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1983
[Phase II comparative trials for confirmation of the null hypothesis. Their interest, particularly in oncology]J L Misset, H Gaget, G Mathé
Transplantation Proceedings|June 1, 1976
Use of soluble histocompatibility antigen(s) in the control of transplantation reactions: possible dissociation of the roles of H-2 and non-H-2 antigens in the prevention of mortality induced by graft-versus-host reactionO Halle-Pannenko, N Abuaf, G Mathé
Pageof 55